AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $109.00
- 52-wk low
- $26.45
- Prev close
- $78.46
- Mkt cap
- $2.60B
- Fwd P/E
- 34.0x
- Beta
- 1.16
Smart money
Earnings
Earnings came in 20.3% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Jun 2025Sep 2025Dec 2025Mar 2026
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $11.2M | $11.8M | $21.8M | $10.9M |
| Cost of what it sold | $214.0K | $196.0K | $0 | $151.0K |
| Gross profit | $11.2M | $11.6M | $21.8M | $10.7M |
| What it spent | ||||
| Research and development | $29.9M | $27.3M | $29.7M | $35.7M |
| Sales and admin | $17.1M | $15.9M | $11.4M | $13.4M |
| Total operating expenses | $47.4M | $43.1M | $40.9M | $49.0M |
| What was left | ||||
| Operating profit | -$36.2M | -$31.5M | -$19.1M | -$38.3M |
| Interest on debt | $5.4M | $6.0M | $9.8M | $7.9M |
| Profit before tax | -$41.8M | -$35.6M | -$36.0M | -$44.8M |
| Tax | -$188.0K | -$33.0K | $31.0K | $64.0K |
| Net profit | -$41.6M | -$35.5M | -$36.1M | -$44.9M |
| EBITDA | -$33.8M | -$29.3M | -$26.1M | -$36.7M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
22 articles · 7 days
Coverage is mixed
Tone of tracked coverage
Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets
Leans bearishAug 19Nektar Therapeutics (NASDAQ: NKTR) insider plans 418-share sale
NeutralAug 18Nektar (NASDAQ: NKTR) exec to sell 186 shares, partly for taxes
NeutralAug 18
